Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03735797 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cancer Stem Cells in Acute Leukemia

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Mar 1, 2025 to Mar 1, 2028
    • Study sites: 2 to 1
    • Study completion date: Mar 1, 2026 to Mar 1, 2029
    v7
  2. Re-verified, no change to tracked fieldsv6
  3. Primary completion date: Jul 1, 2022 to Mar 1, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Jul 1, 2022 to Mar 1, 2026
    • Site details revised at 2 of 2 sites
    v5
  4. Study sites: 1 to 2v4
  5. 2 versions Re-verified since Oct 14, 2019, no change to tracked fieldsv2-v3
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Sanford Health
17 trials monitored
See all monitored trials
Leukemia
2,948 trials monitored
See 180 trials at risk
Descriptive study of acute leukemia patients. Bone marrow aspirate or peripheral blood samples will be analyzed by next-generation sequencing for novel gene signatures and variations in transcriptional and epigenetic regulatory elements such as ARID5B and SALL4 variants.
Trial Details
NCT Number NCT03735797
Lead Sponsor Sanford Health
Conditions
(from sponsor)		 Acute Leukemia
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov